Frost & Sullivan
Frost & Sullivan: Clinical and Cost Benefits to Promote Uptake of Advanced Wound Management Technologies Across Europe
Published in Drug Law Weekly, June 2nd, 2009
New analysis from Frost & Sullivan Western European Advanced Wound Management Market, finds that the market earned revenues of $1.52 billion in 2008 and estimates this to reach $4.35 billion in 2015. The following segments are covered in the research: moist wound dressings segment, antimicrobial wound dressings segment, NPWT segment and advanced therapies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-06-02)
More Articles from Drug Law Weekly
- American Physical Therapy Association
Physical Therapists Advocate for Access to Rehabilitative Services on Capitol Hill - Antiretrovirals
Studies from University of Nigeria provide new data on antiretrovirals - Biosense Webster, Inc.
Benefits of Catheter Ablation with the NAVISTAR® THERMOCOOL® Catheter Sustained for One Year in the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation - Biovail Corporation
Biovail Announces Termination of HSR Waiting Period, Closing of Acquisition of U.S. Rights to Wellbutrin XL® - Bureau of Alcohol, Tobacco, Firearms and Explosives
ATF Teams Up With Partners in Operation Money Train - Campaign for Tobacco-Free Kids
Sen. Judd Gregg Votes to Protect America's Kids from Tobacco - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
